
Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference
InSilicoTrials collaborates with Telomir Pharmaceuticals, applying cutting-edge AI and simulation technologies to optimize the development of Telomir-1, a promising agent in the battle against age-related conditions, by improving its safety profile and reducing development costs. BALTIMORE, March 07, 2024 (GLOBE … Read More

Revolutionizing Healthcare: The Emergence and Impact of Synthetic Data in Life Sciences
The realm of healthcare and life sciences is undergoing a transformative shift, fueled by the advent and integration of data-driven technologies. At the forefront of this revolution is the burgeoning use of synthetic data, a groundbreaking development poised to redefine … Read More

The book 𝗧𝗼𝘄𝗮𝗿𝗱 𝗚𝗼𝗼𝗱 𝗦𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 Published Open Access on Springer Nature
InSilicoTrials is thrilled to announce the publication of “𝙏𝙤𝙬𝙖𝙧𝙙 𝙂𝙤𝙤d 𝙎𝙞𝙢𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝙋𝙧𝙖𝙘𝙩𝙞𝙘𝙚 – Best practices for the use of computational modelling & simulation in the regulatory process of biomedical products ” a crucial document guiding the use of simulation data … Read More

Axoltis Pharma’s Breakthrough in Neurodegenerative Disease Research, Supported by InSilicoTrials
Axoltis Pharma is at the forefront of developing treatments for neurodegenerative diseases, with their phase 1b clinical trial of NX210c marking a notable achievement in the field. This peptide drug candidate has shown promising results following a successful phase 1a … Read More

AI state-of-play around clinical research – BRAINTEASER Community of Practice
The life sciences sector is beginning to experience the transformative effects of AI, with numerous applications offering clinical, operational, and medical advantages. Unlike other industries, life sciences face the unique challenge of safeguarding patient safety and privacy. This has led … Read More

Cutting-edge Big Data initiative seeks to provide crucial support to people affected by Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting BRAINTEASER project during an exclusive … Read More

InSilicoTrials’ Talks Series Listen our IST Customer Testimonial – Yann Godfrin, CEO of Axoltis Pharma
Welcome back to InSilicoTrials’ Talks! We’re excited to launch our IST Customer Testimonials’ initiative, a series dedicated to hearing directly from our clients. Today, we feature Yann Godfrin, CEO of Axoltis Pharma, who joined us for an insightful in silico … Read More

Collaboration Between InSilicoTrials and Biofarma Group Explores the Benefits of In Silico Technology in Clinical Research
InSilicoTrials has collaborated effectively with Biofarma Group to harness the potential of in silico technology for clinical research. In this collaboration, InSilicoTrials utilized its expertise in computational modeling to analyze and reinterpret the clinical trial data of Epatrex, Biofarma Group’s … Read More
Cutting-edge Big Data initiative seeks to provide crucial support to people affected by Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting BRAINTEASER project during an exclusive … Read More

Transforming Fracture Risk Assessment for Cancer Patients with Vertebral Metastases
Cutting-edge EU-funded project METASTRA unites an interdisciplinary team of experts to spearhead a transformative approach to revolutionize fracture risk assessment and personalized treatment for cancer patients with vertebral metastases. A groundbreaking initiative, METASTRA is set to transform the way clinicians … Read More